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ABSTRACT
The ability to generate human-induced pluripotent stem cell (hiPSC)-derived neural cells dis-
playing region-specific phenotypes is of particular interest for modeling central nervous system
biology in vitro. We describe a unique method by which spinal cord hiPSC-derived astrocytes
(hiPSC-A) are cultured with spinal cord hiPSC-derived motor neurons (hiPSC-MN) in a multi-
electrode array (MEA) system to record electrophysiological activity over time. We show that
hiPSC-A enhance hiPSC-MN electrophysiological maturation in a time-dependent fashion. The
sequence of plating, density, and age in which hiPSC-A are cocultured with MN, but not their
respective hiPSC line origin, are factors that influence neuronal electrophysiology. When com-
pared to coculture with mouse primary spinal cord astrocytes, we observe an earlier and more
robust electrophysiological maturation in the fully human cultures, suggesting that the human
origin is relevant to the recapitulation of astrocyte/motor neuron crosstalk. Finally, we test phar-
macological compounds on our MEA platform and observe changes in electrophysiological activ-
ity, which confirm hiPSC-MN maturation. These findings are supported by immunocytochemistry
and real-time PCR studies in parallel cultures demonstrating human astrocyte mediated changes
in the structural maturation and protein expression profiles of the neurons. Interestingly, this
relationship is reciprocal and coculture with neurons influences astrocyte maturation as well.
Taken together, these data indicate that in a human in vitro spinal cord culture system, astro-
cytes support hiPSC-MN maturation in a time-dependent and species-specific manner and sug-
gest a closer approximation of in vivo conditions. STEM CELLS TRANSLATIONAL MEDICINE
2019;00:1–14
SIGNIFICANCE STATEMENT
This study develops a method by which human-induced pluripotent stem cell-derived astrocytes
(hiPSC-A) with distinct spinal cord identity are cocultured with spinal cord motor neurons
(hiPSC-MN) for multielectrode array (MEA) recordings. It also demonstrates that hiPSC-A influ-
ence the morphological, molecular, and electrophysiological maturation of hiPSC-MN. Similarly,
this study shows that hiPSC-A maturation is enhanced by the coculture with hiPSC-MN. This
fully human, spinal cord-specific, coculture platform with MEA analyses provides a new tool for
investigating astrocyte/MN interactions and has the potential to more accurately model human
diseases with spinal cord pathology, including spinal muscular atrophy and amyotrophic lateral
sclerosis.
INTRODUCTION
Human-induced pluripotent stem cell-derived
neurons (hiPSC-N) and astrocytes (hiPSC-A) pro-
vide a powerful platform to recapitulate central
nervous system biology in vitro in both normal
and disease states and to explore therapeutic
strategies for neurological disorders [1]. With the
increasing number of differentiation techniques,
the electrophysiological characterization of
hiPSC-N has become crucial to provide accurate
measures of their function, beyond morphologi-
cal studies, and, ideally, within an environment
that resembles their in vivo counterparts.
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STANDARDS, PROTOCOLS, POLICIES, AND REGULATIONS FOR
CELL-BASED THERAPIES
Multielectrode arrays (MEA) are particularly suited for
these purposes [2] as they enable the recording of large
populations of neurons and their network activity, and have
the potential to inform about neuron–glia interactions. This is
achieved through the detection of extracellular voltages, which
reflect the spike activity of local neuronal populations. The
extracellular nature of the recordings allows for extended
recordings that are particularly suitable for drug testing.
Previous MEA studies have focused on hiPSC-derived corti-
cal neurons, either alone [3–5] or in coculture with primary
rodent cortical astrocytes [6] and more recently with hiPSC-
derived astrocytes [4, 7–9]. Despite an established body of
evidence suggesting that astrocytes contribute to neuronal
electrophysiological maturation by promoting synaptogenesis
[10], MEA- and hiPSC-based paradigms, still influenced by a
traditionally neuron-centered perspective, have not yet been
used to model this unique glial contribution. Well-established
literature [11, 12] has suggested that astrocytes are regionally
heterogeneous and that astrocyte–neuron interactions may be
influenced by their positional identities. However, hiPSC-A
have been largely used as a homogenous and interchangeable
cell type for MEA- and iPSC-based studies.
We describe, for the first time, a method in which the
coculture of spinal cord hiPSC-A and hiPSC-derived spinal cord
motor neurons (hiPSC-MN) is optimized for obtaining MEA
electrophysiological recordings. We use this platform to exam-
ine the bidirectional interactions between hiPSC-A and hiPSC-
MN and to investigate glial contribution to the electrophysio-
logical maturation of hiPSC-MN.
MATERIALS AND METHODS
Generation of hiPSC, hiPSC-MN, and hiPSC-A
hiPSCs were generated using a four-vector method as we have
previously described [13]. For this study, we used three differ-
ent cell lines from healthy subjects: CIPS, GM01582, and CS25.
We used previously described protocols to differentiate hiPSC-
MN [14, 15] and hiPSC-A [15] with spinal cord regional identity
(Fig. 1A), as indicated by the expression of region-specific
markers, that is, choline acetyltransferase (ChAT) [14] and
HOXB4 [15], respectively (Fig. 1A0, 1A00).
MEA Culture
Unless stated otherwise, for cultures on MEA plates
(60MEA200/30iR-Ti-gr, multichannel systems; MCS; Fig. 1B),
we used hiPSC-MN derived from the GM01582 cell line and
hiPSC-A derived from the CIPS cell line. For hiPSC-MN mono-
cultures, neurons were plated after 60DIV at a density of
5 × 105 cells per plate; this neuron density was maintained as
a constant for all culture conditions. For hiPSC-A monocul-
tures, astrocytes were plated after 90DIV at a density of
1 × 105 cells per plate. For the “astrocyte first” serial
coculture, we first plated hiPSC-A cultured for 86DIV at a den-
sity of 1 × 105 cells per plate; 4 days later, we added hiPSC-
MN cultured for 60DIV. For the “neuron first” serial coculture,
we first plated hiPSC-MN cultured for 56DIV; 4 days later, we
added hiPSC-A cultured for 90DIV and then plated at a density
of 1 × 105 cells per plate. For the simultaneous coculture of
hiPSC-A/hiPSC-MN, both cell types were mixed and plated
simultaneously on MEA plates at the densities noted above,
after 90DIV and 60DIV, respectively (Fig. 1C).
As variations of the above-mentioned simultaneous
coculture, we also used the following: hiPSC-A which had been
cultured for 60DIV (“immature hiPSC-A”) instead of 90DIV, a
lower density of hiPSC-A (i.e., 0.5 × 105 cells per plate instead
of 1 × 105 per plate), and hiPSC-A differentiated from same
iPSC line (“isoclonal”) as hiPSC-MN (i.e., both lines were
GM01582), instead of using different control iPSC lines for
astrocytes (CIPS and CS25) and neurons (GM01582;
i.e., “heteroclonal”). We also compared isoclonal versus
heteroclonal simultaneous cocultures using a different hiPSC-
MN line (i.e., CS25). Finally, we used primary mouse spinal
cord astrocyte (“mouse A”), instead of human iPSC-A, simulta-
neously cocultured with hiPSC-MN for some studies.
MEA Recordings
The MEA plates used for this study have 60 electrodes, includ-
ing 59 active and 1 inactive that represents the reference for
unipolar acquisition. All recordings were conducted using an
MEA2100 System (MCS) on a stage maintained at 37C.
The following electrophysiological parameters were ana-
lyzed: spike frequency, burst rate, and percentage of spiking and
bursting electrodes. Functional connectivity graphs based on
spike frequency were generated as recently described [16]. The
recording of the baseline activity of MEA plates was performed
weekly over a 1-minute period for 4 weeks after plating. Repre-
sentative raw voltage waveforms, which were used for quantita-
tive analyses are shown in Supporting Information Figure S1.
For pharmacological testing, we recorded baseline MEA
activity for 1 minute, activity 1 minute after 100 μl “fresh”
medium exchange with the drug vehicle, and 1–10 minutes
after the exchange of 100 μl of medium containing the com-
pound of interest and the vehicle.
We tested the following compounds targeting ion channels
and/or neurotransmitter receptors, based on the published liter-
ature [6]: 100 mM potassium chloride (KCl); 5 μM of the
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/
kainate receptor agonist, kainic acid (KA; Abcam, Cambridge,
UK); 50 μM of the AMPA/kainite receptor antagonist,
cyanquixaline (CNQX; Sigma–Aldrich, St. Louis, MO, USA); 10 μM
of the gamma amino butyric acid (GABA) receptor antagonist,
bicuculline (Sigma–Aldrich, St. Louis, MO, USA). We also tested
compounds targeting glia and verified their effect on neuronal
firing; these included: GAP19 (Tocris, Bristol, UK), a connexin
43 hemichannel blocker [17], at concentrations of 34 μM and
340 μM, and dihydrokainic acid (DHK; Tocris, Bristol, UK), an
excitatory amino acid 2 (EAAT2) selective blocker, at concentra-
tions of 50 μM and 300 μM [18, 19]. We analyzed the effects of
the above-mentioned compounds on 3 MEA plates at two differ-
ent time points and when at least one electrode showed spike
frequency >0: at week 1 or 2 of culture, and at week 3 or 4.
Data Presentation and Statistical Analysis
All data were analyzed using Graph Pad Prism software
(La Jolla, CA). Data are presented as bar graphs for mean 
SEM, with individual observations visualized as scatter plot, or
as box (interquartile range and median) and whiskers (mini-
mum and maximum). Data were analyzed using one-way anal-
ysis of variance, followed by Tukey’s test for multiple
comparisons and a two-tailed unpaired t test, as appropriate.
© 2019 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by
Wiley Periodicals, Inc. on behalf of AlphaMed Press
STEM CELLS TRANSLATIONAL MEDICINE
2 Human Motor Neuron and Astrocytes in MEA
The statistical significance was set at p < .05. Unless stated
otherwise, all experiments were performed in technical
triplicates.
For qPCR analyses, the ΔΔCT values were normalized to
monocultures (i.e., “hiPSC-A” or “hiPSC-MN”) to account for
the effect of cocultures.
Figure 1. (A): Schematic illustration of the differentiation protocol to generate spinal cord human-induced pluripotent stem cell-derived
astrocytes (hiPSC-A) and hiPSC-derived motor neurons (hiPSC-MN). Two representative immunofluorescence images of positional identity
markers HOXB4 (A0), a transcription factor involved in spinal cord development, and ChAT (A00), an enzyme responsible for the biosynthe-
sis of acetylcholine in spinal cord motor neurons. (B): Photograph of multielectrode array (MEA) plate with detail on its set of 60 micro-
electrodes and schematic illustration of an individual electrode. (C): Diagram of hiPSC-A/-MN cultures on MEA plate: (1) hiPSC-A or -MN
monocultures, where astrocytes or neurons were cultured alone, (2) simultaneous coculture, where both cell types were mixed and
plated simultaneously, and (3) serial cocultures, where hiPSC-A (left) or hiPSC-MN (right) where plated alone prior to the addition of neu-
rons and astrocytes, respectively. Abbreviations: LDN, LDN193189; FBS, fetal bovine serum; RA, retinoic acid; SB, SB431542; PMN,
purmorphamine. Illustration created with BioRender.
www.StemCellsTM.com © 2019 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by
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For the analysis of MEA baseline activity, we considered
the active electrodes only (i.e., electrodes with spike frequency
>0), and their mean activity as a measure of the overall elec-
trophysiological activity of the cell culture. To account for vari-
ability in the culturing process, analyses were performed only
on parallel plating.
In order to define the effect of KCl and neurotransmitter
modulators on MEA activity, we recorded for 3 minutes and
compared the mean activity at baseline (1 minute), after
medium with vehicle exchange (1 minute) and after drug addi-
tion (in the same volume of medium and with the same con-
centration of vehicle; 1 minute). For GAP19, we recorded for
3 minutes after drug addition, since changes in MEA activity
were slightly slower. For DHK, we recorded for 10 minutes
after drug addition to detect even slower effects; since
changes in the pH in the medium could occur at atmospheric
conditions for longer recordings, we compared the activity
after DHK addition to parallel plates where we evaluated
changes up to 10 minutes after the addition of the vehicle. All
experiments were performed in experimental triplicates. Addi-
tional methods can be found in Supporting Information.
RESULTS
hiPSC-A Influence hiPSC-MN Maturation
In order to develop a reliable and reproducible platform to
study the influences of hiPSC-A on hiPSC-MN electrophysiol-
ogy, we first sought to optimize the cell culturing protocol on
MEA plates, and to determine the optimal sequence of plating
hiPSC-A and hiPSC-MN (Supporting Information Fig. S2).
Human iPSC-A, after proper treatment of the plate surface and
at the densities noted above, generated a confluent monolayer
(Supporting Information Fig. S2A, Box 1). The culture of hiPSC-
MN alone resulted in large aggregates of neurons, which were
arranged over a few electrodes (Supporting Information
Fig. S2A, Box 2 and Supporting Information Fig. S2B). The cul-
ture of hiPSC-A into a monolayer followed by plating hiPSC-
MN resulted in fewer large neuronal aggregates and a more
even distribution of cells amongst the electrodes (Supporting
Information Fig. S2A, Box 3). Plating hiPSC-MN followed by the
addition of hiPSC-A had similar results (not shown). Finally, we
found that the simultaneous culture of hiPSC-A and hiPSC-MN
resulted in more evenly distributed populations of MN with
fewer aggregates of MN and fewer numbers of cells in each
aggregate (Supporting Information Fig. S2A, Box 4 and
Supporting Information Fig. S2B). These observations were
consistent among 15 different MEA cultures.
We then asked whether the presence of astrocytes and
the time in culture would result in a change in neuronal sub-
type composition. When hiPSC-MN were cultured in monocul-
tures for 1 week, we found that >90% of TUJ1+ neurons had a
motor neuron identity as demonstrated by ChAT immunoreac-
tivity (Supporting Information Fig. S3A). This percentage was
not significantly different when compared with astrocyte–
neuron cocultures (93.1%  3.0% vs. 92.1%  4.2%, respec-
tively). This result was confirmed by ISL-1/2 staining of a sub-
set of MN [20], which was between 25% and 30% of TUJ1+
cells for both conditions (28.4%  0.8% vs. 27.4%  1.5%,
respectively). Consistent with the spinal cord identity of the
neuronal cultures, less than 2% of our neuronal population
was positive for CTIP2 (a marker of corticospinal motor neuron
identity) [21]. Beside ChAT+ motor neurons, neuronal cultures
showed a small proportion (<5%) of GABAergic interneurons,
as suggested by the immunoreactivity to GAD67 [22]. These
percentages were not influenced by the time in culture, as
they were not significantly different after 4 weeks of monocul-
ture or coculture (Supporting Information Fig. S3A), thus rein-
forcing previous observations that spinal cord motor neuron
fate is determined early during hiPSC differentiation [23].
The immunoreactivity for neuronal neurotransmitter
receptors (Fig. 2), including AMPA, GABA, and glycine were all
significantly increased by the presence of hiPSC-A, both
after 1 week (glutamate 2/3 receptor: 7.1%  0.6%
vs. 28.9%  0.9%, p < .001; GABA receptor: 6.6%  1.1%
vs. 16.4%  0.9%, p < .001; glycine receptor: 6.2%  1.3%
vs. 10.9%  2.0%, p < .05) and 4 weeks (glutamate 2/3 recep-
tor: 7.3%  0.4% vs. 28.3%  2.5%, p < .001; GABA receptor:
4.8%  1.4% vs. 17.4%  1.9%, p < .001; glycine receptor:
5.1%  0.4% vs. 10.2%  1.6%, p < .05) of coculture. In paral-
lel to neurotransmitter immunoreactivity, we found that the
number of synapses, as demonstrated by PSD95/syn-
aptophysin staining was significantly increased when hiPSC-
MN were cocultured with hiPSC-A (Fig. 2). The number of syn-
apses increased over time with the culture of hiPSC-MN alone
(6.9  0.8 vs. 54.2  8.5, p < .001), but to a greater degree
(25.5  2.3 vs. 85.1  5.1, p < .01) in the presence of astro-
cytes (week 1 monoculture vs. coculture, p < .01; week
4 monoculture vs. coculture, p < .001; Fig. 2).
We also investigated motor neuron maturation as defined
by morphological parameters outlined in Supporting Informa-
tion Figure S4. First, we considered (n = 100) randomly
selected hiPSC-MN neurites in monocultures or cocultures,
and found that the mean value of the diameter distribution
was significantly different amongst conditions: 1.5 μm  0.6 μm
versus 2.1 μm  0.7 μm for week 1 motor neurons in mono-
culture versus coculture, respectively (p < .001), and
2.2 μm  0.6 μm versus 3.0 μm  1.7 μm for week 4 monocul-
tures versus cocultures, respectively (p < .001). Notably, after
4 weeks of coculture, a subgroup of larger diameter neurites
emerged, as seen in the histogram in Supporting Information
Figure S4. We then considered the largest neuronal processes
of n = 50 randomly selected neurons, and found that those
increased over time, with slightly higher values in the presence
of hiPSC-A though not statistically significant: 5.4 μm  1.8 μm
versus 9.1 μm  3.1 μm, p < .001 for monocultures, and
5.9 μm  2.7 μm versus 9.7  3.9 μm, p < .001 for cocultures.
The area of the neuronal cell body (n = 50 neurons) signifi-
cantly increased over time in hiPSC-MN monocultures
(125.9 μm2  28.9 μm2 vs. 203.9 μm2  32.6 μm2, p < .001),
and more robustly (p < .001) in the presence of hiPSC-A
(131.1 μm2  26.1 μm2 vs. 230.9 μm2  26.3 μm2, p < .001).
Finally, to quantify the complexity of connections between
neurons we performed a Sholl analysis and found that the
mean number of intersections per neuron increased signifi-
cantly overtime (2.2  0.3 vs. 14.5  0.9, p < .05), particularly
(p < .001) when hiPSC-MN where in coculture with hiPSC-A
(1.9  0.2 vs. 38.6  8.3, p < .001).
Through parallel qPCR experiments, we sought to verify
our observations from immunostaining and examine the effect
of human astrocyte maturity as well as species-specific interac-
tions on neuronal maturation (Supporting Information Fig. S5).
© 2019 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by
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We confirmed that spinal cord motor neuron identity, as
defined by ChAT expression, is not significantly influenced by
hiPSC-A coculture at either 60 or 90DIV nor is it influenced by
coculture with mouse astrocytes. In contrast, the expression of
genes required for the biosynthesis of neurotransmitter recep-
tors (GRIA2, 3 for AMPA receptor, GABRA1 for GABA receptor,
and GLRA1 for glycine receptor) and of GABA (GAD1) is partic-
ularly enriched in the cocultures with hiPSC-A, in a time-
dependent manner (Supporting Information Fig. S5). We found
that even though the presence of immature hiPSC-A or mouse
astrocytes increased neuronal maturation when compared
with hiPSC-MN monocultures, particularly at the later time
point, this effect was consistently lower than that observed for
cocultures with mature (i.e., cultured for 90DIV prior to use)
human-derived astrocytes (Supporting Information Fig. S5).
hiPSC-MN Influence hiPSC-A Maturation
We sought to investigate astrocyte–neuron interactions in our
human spinal cord iPSC-based platform, as their reciprocal
maturation could dynamically influence the electrophysiologi-
cal activity of hiPSC-MN recorded by MEA.
Confirming previous descriptions by Roybon et al. [15] and
by our group [24], we defined a maturing glial identity of our
hiPSC-A, as shown by immunoreactivity of cells for S100β
(78.9%  4.2%), GFAP (41.2%  3.3%), EAAT2 (8.1%  1.6%),
and Cx43 (22.7%  2.5%; Fig. 3). Spinal cord regional identity
was suggested by high immunoreactivity (92.5%  1.4%) for
HOXB4 (Supporting Information Fig. S3B). These astrocytes did
not show relevant immunoreactivity for CD51 (4.1%  0.2%),
a marker recently associated with a cortical identity [25]
(Supporting Information Fig. S3B).
Figure 2. (A): Immunofluorescent quantification of neurotransmitter receptors and synapses. Neurotransmitter receptors (glutamate,
gamma amino butyric acid [GABA], and glycine) were quantified as percentage of TUJ1 immunopositive cells (mean of n = 3 coverslips
per culture condition and time point). Synapses were counted as colocalized punctae of synaptophysin, a presynaptic marker, and PSD95,
a postsynaptic marker, per individual neuron (mean of n = 3 coverslips per condition, with a minimum of 10 neurons per coverslip).
Human-induced pluripotent stem cell-derived motor neurons (hiPSC-MN) monocultures (MN) versus hiPSC-MN + hiPSC-derived astrocytes
(hiPSC-A) cocultures (MN + A) were compared within each time point after plating (*), that is, week 1 (white bar) and week 4 (gray bar).
Similarly, time point observations (week 1 vs. week 4) were compared within each condition (^).* or ,^ p < .05; ** or ^ ,^ p < .01; *** or
^^^, p < .001. (B): Representative immunohistochemical images for neurotransmitter receptors and synapses. Top: Immunoreactivity for
receptors, that is, glutamate 2/3 receptor, GABA A receptor, and glycine receptor in hiPSC-MN + A cocultures compared with hiPSC-MN
monocultures. Representative images were taken 1 week after plating. Bottom: Colocalized synaptophysin/PSD95 punctae per neuron in
hiPSC-MN + A cocultures (b, d) compared with monocultures (a, c), from week 1 (a, b) to week 4 (c, d). Abbreviations: GABA-R, GABA A
receptor; Glu-R, glutamate 2/3 receptor; Gly-R, glycine receptor.
www.StemCellsTM.com © 2019 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by
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We then found that the coculture of hiPSC-A with hiPSC-
MN, when compared with hiPSC-A monocultures, increased
the immunoreactivity for GFAP (52.0%  3.5%, p < .01), and
Cx43 (47.9%  1.2%, p < .001), thus suggesting a more mature
astrocyte phenotype. This enhanced glial maturation was even
more marked after 4 weeks of coculture, when, in addition to
GFAP (73.9%  1.6% vs. 54.9%  5.6%, p = .001) and Cx43
(78.5%  4.8% vs. 47.9%  1.2%, p < .001), EAAT2 immunore-
activity increased significantly (72.9%  3.5% vs. 55.6% 
2.9%, p < .001; Fig. 3).
The qPCR experiments confirmed the trends observed with
immunostaining at mRNA expression levels and on a larger set
of astrocyte genes, which included also AQP4 and ALDH1L1.
Some disparities between qPCR and ICC findings were evident,
notably: Cx43 expression was comparable between monocul-
tures and cocultures at week 1 and EAAT2 mRNA levels were
not detected at week 1.
We used the qPCR platform to examine less mature hiPSC-
A cultured for only 60DIV prior to use, and to investigate their
maturation in the presence of hiPSC-MN. One week after their
plating in coculture, qPCR experiments suggested an immature
status of this glial population when compared with “mature”
(i.e., 90DIV) hiPSC-A in monoculture and coculture. After
4 weeks of coculture, these cells remained significantly less
mature, particularly when considering EAAT2 and GFAP
expression levels, which were negligible. AQP4 and particularly
Cx43 were two exceptions, as their expression levels in imma-
ture hiPSC-A were comparable for AQP4, or even higher for
Cx43 (p < .001), than the more mature hiPSC-A (cultured for
90DIV prior to use) in monoculture or coculture (Supporting
Information Fig. S6).
MEA Models hiPSC-A and hiPSC-MN Interactions
Given the striking hiPSC-A-dependent changes in hiPSC-MN
maturation by immunofluorescence and qPCR, we sought to
determine whether these structural changes and altered
expression profiles are meaningfully related to altered electro-
physiologic function of neurons. We plated hiPSC-MN in
monocultures or cocultures with astrocytes on MEA plates that
were either plated concurrently or serially. We recorded from
the MEA plates at 1, 2, 3, and 4 weeks after plating (Fig. 4).
We noted increases in all electrophysiological parameters eval-
uated (spike frequency, burst rate, percentage of electrodes
spiking, and percentage of electrodes bursting) over time
(Fig. 4A–4D). The changes over time occurred for all culture
conditions (hiPSC-A/hiPSC-MN simultaneous coculture, hiPSC-
MN followed by hiPSC-A, hiPSC-A followed by hiPSC-MN, and
hiPSC-MN culture alone; p < .001 for week 1 vs. week 4 com-
parisons). However, the difference in the maturation between
simultaneously cultured hiPSC-A and hiPSC-MN when
Figure 3. (A): Immunofluorescence quantification of astrocyte-specific markers. We considered the total number of DAPI+ cells which
were negative for TUJ1 immunostaining as an approximation of the number of astrocytes in human-induced pluripotent stem cell-derived
astrocytes (hiPSC-A) + motor neurons (MN) cocultures (A + MN), and hiPSC-A monocultures (A); astrocyte-specific markers are expressed
as percentage of DAPI+ and TUJ1− cells. S100β+ marks a less mature stage of astrocytic differentiation. Conversely, GFAP, Cx43, and EAAT2
are markers of maturing/mature astrocytes. Experimental conditions (hiPSC-A monocultures vs. hiPSC-MN + hiPSC-A cocultures) are com-
pared within each time point (*). Time point observations (week 1 vs. week 4) are compared within each condition (^). * or ,^ p < .05; **
or ^ ,^ p < .01; *** or ^^ ,^ p < .001). (B): Representative immunohistochemical images of astrocyte markers. Reciprocal changes of S100β
and GFAP according to culture conditions and time in vitro. Immunoreactivity for Cx43 and EAAT2 in hiPSC-A monoculture and coculture,
at week 1 and week 4 after plating.
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compared with hiPSC-MN cultured alone was most dramatic
with the spike frequency, burst rate, number of spiking, and
number of bursting electrodes higher in the simultaneous
coculture at all time points. Although less marked and uniform
over time points, the simultaneous cocultures also showed
greater degrees of neuronal activity when compared with
serial cocultures. We did not see any evidence of spontaneous
synchronous bursting activity, which is thought to reflect high
degrees of neuronal connectivity [18, 26] (not shown). For all
conditions, MEA plates with hiPSC-A alone were recorded as
controls, and did not show any measurable electrophysiologi-
cal activity within the 4-week period of recording, confirming
the relatively pure composition of our astrocyte cultures
(Supporting Information Fig. S3B). We calculated the percent-
age of active electrodes whose spike activity persisted
throughout the 4 weeks of recordings and defined this param-
eter as “consistently active electrodes” (Fig. 4E). We noted
that electrophysiological consistency was influenced by the
sequence of culturing hiPSC-A and hiPSC-MN. Indeed, approxi-
mately 45.8%  4.4% of electrodes remained persistently
active over 4 weeks following the simultaneous culture of
iPSC-A and iPSC-MN. The culture of either hiPSC-A first
(25.4%  3.4%) or hiPSC-MN first (27.1%  4.5%) were not
significantly different from each other, but had lower electro-
physiological consistency than the simultaneous culture
(p < .05). Furthermore, only 13.0%  4.2% of electrodes
showed persistent spike activity when hiPSC-MN were cultured
in the absence of hiPSC-A (p < .001; Fig. 4E).
In addition to the 4 week recordings, we tested the long-
term survival of our optimized coculture, and succeeded in
maintaining these cells in culture for up to 9 months. A
trending increase in spike frequency was noted over time
(Supporting Information Fig. S7). This is consistent with data
derived from cortical hiPSC-neurons (hiPSC-N) [6].
We also examined whether the plating density of hiPSC-A
influences hiPSC-MN activity (Fig. 5A). The spike frequency, per-
centages of electrodes exhibiting spikes, and percentages of
electrodes exhibiting bursts were significantly increased across
all time points in cocultures with a density of 1 × 105 astrocytes
per plate when compared with a lower density of 0.5 × 105
Figure 4. The electrophysiological maturation of human-induced pluripotent stem cell-derived motor neurons (hiPSC-MN) by hiPSC-
derived astrocytes (hiPSC-A) over time. (A–D): Electrophysiological parameters were recorded at weekly intervals for hiPSC-MN in mono-
culture as well in coculture with hiPSC-A. Data are presented as mean  SEM (mean of n = 3 multielectrode array [MEA] plates). (E): The
percentage of consistently active electrodes represents populations of neurons with stable electrophysiological activity over individual
electrodes (n = 3 cultures). Comparisons of hiPSC-MN monocultures with the two hiPSC-MN/A serial cocultures (*). Comparisons between
the simultaneous coculture and the two serial cocultures (^). * or ,^ p < .05; ** or ^ ,^ p < .01; *** or ^^ ,^ p < .001.
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astrocytes per plate. However, when even higher densities of
astrocytes (2 × 105 astrocytes per plate) were used, there was
poor cell adhesion immediately after plating, which led to lifting
of the cultures (not shown). These findings were correlated with
a higher percentage of “consistently active electrodes” in the
cocultures with 1 × 105 astrocytes per plate when compared
with a lower density of 0.5 × 105 astrocytes per plate (43.6% 
2.4% vs. 28.8%  2.6%, p < .05).
To assess whether astrocyte age and maturity prior to
coculture with hiPSC-MN would influence hiPSC-MN electro-
physiological activity, we cultured hiPSC-A for 60 days prior to
the coculture with hiPSC-MN. When compared to cocultures
with mature (90DIV) hiPSC-A, these cells had a significantly
reduced capacity to support hiPSC-MN spike frequency and
number of active electrodes (Fig. 5B). This phenomenon per-
sisted over the 4-week time course (p < .05 for all
comparisons). We also observed that the presence of imma-
ture hiPSC-A determined reduced consistency of neuronal fir-
ing (53.1%  2.0% vs. 16.4%  1.1%, p < .001).
Given that, using hiPSC raises the question as to whether
there could be variations in electrophysiological properties
amongst different iPSC lines, we compared simultaneous
cocultures that were “isoclonal” (hiPSC-A and -MN differenti-
ated from the same GM01582 line) or “heteroclonal” (hiPSC-A
from CIPS line or CS 25 line and hiPSC-MN from GM01582
line). We did not appreciate significant line-specific differences
in electrophysiological activity over time (Fig. 5C); this was
paralleled by similar percentages of consistently active elec-
trodes (43.5%  4.3%, 50.6%  4.7%, and 48.6%  3.5%). We
confirmed these observations using another hiPSC-MN line
(i.e., CS25), and recording from isoclonal versus heteroclonal
cocultures (Fig. 5D).
Figure 5. Astrocyte variables influencing the electrophysiological maturation of human-induced pluripotent stem cell-derived motor neu-
rons (hiPSC-MN) in coculture. (A): Influence of hiPSC-derived astrocytes (hiPSC-A) density on the electrophysiological maturation of hiPSC-
MN as measured by multielectrode array (MEA). (B): Effect of immature versus mature astrocytes on neuronal maturation as measured by
MEA. (C, D): Influence of hiPSC-A and hiPSC-MN respective iPSC-line origin on the electrophysiological maturation of hiPSC-MN. The source
of hiPSC-MN was the control GM01582 line in (C), and the control CS25 line in (D). In both figures, MN were cocultured with control hiPSC-
A lines (CIPS, CS25, and GM01582 lines). (E): Effect of the species origin (mouse primary spinal cord astrocytes vs. human iPSC-A) on hiPSC-
MN maturation, as recorded by MEA. Data are the mean of n = 3 MEA plates for all conditions. *, p < .05; **, p < .01; ***, p < .001.
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Figure 6. Human-induced pluripotent stem cell-derived astrocytes (hiPSC-A) influence the responses of hiPSC-derived motor neurons
(hiPSC-MN) to neurotransmitters. (A): hiPSC-MN responses to compounds acting on neurotransmitter receptors (KA, cyanquixaline
[CNQX], and bicuculline) and to a nonspecific depolarizing agent (KCl), in hiPSC-MN/-A cocultures, over time (week 1–2 after plating—
white bars and week 3–4 after plating—gray bars). The activity recorded by MEA plates after vehicle addition (−) and after drug addition
(+) was normalized to the baseline activity (horizontal dashed line; mean of n = 3 independent experiments per drug and time point).
Comparisons between activity after vehicle and after drug addition (*). Time point observations (week 1–2 vs. week 3–4) are compared
within each condition (^). * or ,^ p < .05; ** or ^ ,^ p < .01; *** or ^^ ,^ p < .001. (B): Sample of real-time recording of hiPSC-MN/hiPSC-A
cocultures by MEA. Two representative recordings of electrophysiological activity are shown: the effect of the addition of KA (left) and
CNQX (right) compared with the addition of the vehicle and to baseline activity. Top histograms represent the number of spikes per elec-
trode and per time point of recording, whereas the bottom raster plots represent overall electrodes showing spiking activity per time
point. Abbreviations: KA, kainic acid; KCl, potassium chloride.
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Most studies utilizing MEA for recording from human iPSC-
neurons have used rodent astrocytes in the context of
coculture systems [6, 8]. Our results demonstrate that mouse
spinal cord astrocytes resulted in a slower maturation of the
electrophysiological activity of hiPSC-MN when compared with
cocultures with hiPSC-A. MEA activity became comparable
between these two conditions only after 4 weeks of coculture.
Overall, the percentage of consistently active electrodes was
reduced in the mouse/human cocultures (37.8%  2.0%
vs. 53.1%  2.0%, p < .01; Fig. 5E).
MEA as a Screening Platform for Drugs Targeting
hiPSC-MN and hiPSC-A
Beyond the spontaneous electrophysiological activities of
hiPSC-MN, we examined the response of these cells, in mono-
culture or coculture, to compounds targeting ion channels and
neurotransmitter receptors. When cultured alone, hiPSC-MN
responded to the application of 100 mM of potassium chloride
(KCl), a nonspecific depolarizing agent, with an increase in
spike frequency without any change in the number of spiking
or bursting electrodes (Supporting Information Fig. S8).
Figure 7. Compounds targeting astrocytes affect human-induced pluripotent stem cell-derived motor neurons (hiPSC-MN) electrophysi-
ology as recorded by multielectrode array (MEA). (A): Effects of GAP19, a specific Cx43 hemichannel blocker, on neuronal activity, in
hiPSC-MN/-A cocultures, over time (week 1–2 after plating—white bars, and week 3–4 after plating—gray bars; −, vehicle; +, 34 μM; ++,
340 μM). Changes on hiPSC-MN electrophysiological activity after the addition of DHK (−, vehicle; +, 50 μM; ++, 300 μM). The electro-
physiological parameters were normalized to the baseline activity recorded for 1 minute (dashed line; mean of n = 3 independent experi-
ments per drug and per time point; * or ,^ p < .05; ** or ^ ,^ p < .01; *** or ^^ ,^ p < .001). (B): Representative MEA raster plots of
electrophysiological activity following the addition of GAP19 (left) and DHK (right). Abbreviation: DHK, dihydrokainic acid.
© 2019 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by
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However, the application of neurotransmitter agonists/antago-
nists did not alter MEA electrophysiological parameters
(Supporting Information Fig. S8).
In contrast, when recording from hiPSC-A/hiPSC-MN simul-
taneous cocultures (Fig. 6), we found that the AMPA/kainate
receptor agonist, KA, and antagonist, CNQX, induced appropri-
ate (i.e., an increase for KA and a decrease for CNQX) changes
in the spike frequency together with a significant variation of
bursting activity. These responses were time-dependent, as
they were absent at earlier stages of maturation in vitro (week
1–2 after plating), while they appeared after 3–4 weeks of
coculture. The addition of bicuculline, a GABA antagonist, did
not significantly change the overall MEA activity, although
there was a trend toward increased spike frequency and per-
centage of bursting electrodes in older cocultures. In contrast
to the neurotransmitter modulators, KCl showed depolarizing
effects across all time points (Fig. 6). We did not observe any
hypersynchronous bursting activity occurring after the applica-
tion of any of these compounds.
We used this screening platform to test the effect of neu-
rotransmitter agonists/antagonists on cocultures of hiPSC-MN
with mouse primary spinal cord astrocytes (Supporting Infor-
mation Fig. S9). In contrast to fully human cocultures, we did
not observe significant electrophysiological responses to drugs
acting on neurotransmitter receptors, although a trend of
increased activity in response to KA and bicuculline and
reduced activity after the application of CNQX was evident.
To examine the immediate effect of altered astrocyte func-
tion on neuronal firing, we used our MEA platform to test
compounds targeting astrocyte specific transporters, and eval-
uate their indirect influence on neuronal firing. The application
of GAP19, a connexin 43 hemichannel blocker, resulted in a
significant reduction of MEA activity (spike frequency and
bursting electrodes). This phenomenon was apparent across all
time points of coculture and was dose-dependent (Fig. 7). To
ensure that this effect was mediated by astrocytes, we tested
the drug on hiPSC-MN monocultures, and did not appreciate
any variation in neuronal activity (Supporting Information
Fig. S8). The selective glutamate transporter (EAAT2) antago-
nist, DHK, caused a reduction in MEA activity, which appeared
within 10 minutes of recording. This effect was dose-dependent,
and could be appreciated only in coculture at later time points
(weeks 3–4; Fig. 7).
DISCUSSION
To the best of our knowledge, this study is the first to investi-
gate how hiPSC-derived glia, differentiated into a distinct spi-
nal cord astrocyte identity [15], influence the morphological,
molecular, electrophysiological and pharmacological properties
of hiPSC-MN in a MEA-based platform. The regional specificity
of this paradigm is particularly relevant in precision medicine
strategies for modeling neurological diseases. Previous litera-
ture on MEA applied to hiPSC studies have relied exclusively
upon hiPSC-derived cortical neurons, for in vitro modeling of
epilepsy and seizures [7, 8]. Although recent MEA studies have
used neurons cocultured with human iPSC-derived astrocytes
[4, 7–9], less attention has been given to how astrocytes may
influence neuronal electrophysiological activity—particularly in
the context of human biology.
To establish a hiPSC platform of spinal cord astrocyte/MN
coculture, we first optimized the sequence of coculture. As
observed by others [27], the culture of hiPSC-MN in the
absence of astrocytes resulted in a significant number of large
aggregates of iPSC-MN that morphologically made it difficult
to discern specific boundaries and connections amongst these
cells. Furthermore, these cultures demonstrated diffuse neuro-
nal mobility, as reflected electrophysiologically by a low num-
ber of electrodes with persistent activity for the 4-weeks
recording period. The culture of either hiPSC-A followed by
plating of hiPSC-MN or the converse, resulted in fewer neuro-
nal aggregates and an increase in the number of MEA elec-
trodes showing persistent activity. Finally, we observed that
the simultaneous plating of hiPSC-A and hiPSC-MN morpholog-
ically resulted in a much more homogeneous distribution of
hiPSC-MN, and in the greatest number of electrodes showing
persistent activity.
The observation that neuronal subtypes and cell densities
(both glial and neuronal) did not change over time, made us
more confident that the neuronal activity, as recorded by
MEA, was a reflection of neuronal maturation. A stable com-
position of hiPSC-derived neuronal subtypes over time has
been observed by others [23], and may reflect an early deter-
mination of neuronal subtypes during neural progenitor cell
differentiation. Our data suggest that the majority of our cells
are spinal cord motor neurons (positive for ChAT and, to a
lesser extent, for ISL1/2), expressing appropriate neurotrans-
mitter receptors, with AMPA receptors being more represen-
ted than GABA and glycine receptors, as would be expected in
the spinal cord. Importantly, in accordance with our protocol
of ventralization and caudalization, and in contrast to previous
studies involving hiPSC-cortical neurons [7, 8], only a very
small percentage of neurons were corticospinal CTIP2+ motor
neurons. Neuronal maturation overtime, and particularly in
the presence of astrocytes, was reflected morphologically by
increased cell soma and neurite sizes, and by increased num-
ber and complexity of neurites. These features determine an
enhanced ability of individual neurons to generate action
potentials and to synapse with neighboring cells [28]. The
degree of morphological maturation of our neuronal popula-
tion resembles that of MN derived from human embryonic
stem cells [29] and of cortical hiPSC-N [6, 8], although it is still
reduced when compared with the human alpha motor neu-
rons in adults [30, 31].
We used this optimized coculture platform for MEA
recording to examine hiPSC-A contributions to motor neuron
electrophysiology. We observed that astrocytes influenced
hiPSC-MN electrophysiology over time with increases in spik-
ing and bursting activity that far exceeded the activity of
hiPSC-MN cultured in the absence of astrocytes. These findings
are consistent with previous observations on human iPSC-
derived cortical neurons [4, 9, 32–38]. Moreover, the spike fre-
quencies we recorded are comparable to those reported by
MEA studies with cortical hiPSC-N [6, 8, 39] or with rodent pri-
mary MN [36, 40, 41]. These firing rates are lower than those
observed in vivo and probably reflect reduced neu-
romodulatory influences from afferent or descending inputs
[42, 43]. In contrast to MEA studies utilizing cortical neurons
[4, 8, 40, 41], we did not appreciate the presence of synchro-
nized bursting activity among spinal cord hiPSC-MN up to
9 months of culture in vitro. Given that, morphologically we
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appreciate evidence of complex networks and well-developed
synapses, the lack of these patterns may suggest a regional dif-
ference between cortical and spinal cord hiPSC-MN and/or -A.
Organotypic cultures and dissociated cells from rodent spinal
cords disclose patterns of rhythmic bursting activity, which
resemble the oscillatory patterns of locomotion in vivo or the
“fictive locomotion” activity recorded from spinal cord prepa-
rations in vitro, and may be generated by the same locomotor
networks and/or neuronal subtypes [44]. The neurochemical
basis of similar patterns, with potential roles of GABA, glycine
and NMDA receptors [41, 45], and their neuronal contributors,
with recent identification of rhythm-generating excitatory
interneurons (such as rodent CHX10+ and SHOX2+ interneu-
rons) [46] represent a field of ongoing research, which may
benefit from a MEA and fully human spinal cord platform,
although they were not the focus of this study [47, 48].
We then determined that the ratio of hiPSC-A to hiPSC-
MN influenced the activity of MN with higher concentrations
of hiPSC-A providing a significant increase in hiPSC-MN firing.
The significantly lower hiPSC-MN firing when cultured with
60-day astrocytes, which was paralleled by qPCR profiling of
hiPSC-MN, suggest that for the purposes of examining electro-
physiological activity, more mature astrocytes seem to be
essential.
One of the concerns regarding the use of human iPSCs, as
opposed to rodent astrocytes, is that genetic heterogeneity
among individuals is much greater than in rodents thus making
interpretation of results more challenging. Our data provide
early evidence that the source of control iPSC-derived astro-
cytes does not significantly influence iPSC-MN activity. Simi-
larly, we observed similar degrees of MEA activity
independently of the source of hiPSC-MN. In order to confirm
these observations, a larger set of hiPSC-A/-MN lines and their
potential combinations will be needed in future studies.
Given that hiPSC-A differentiation requires longer time in
culture, generates less mature astrocytes, and produces fewer
astrocytes than primary rodent-derived astrocytes, we exam-
ined whether there was a difference in neuronal activity of
cocultures with hiPSC-A compared with mouse primary spinal
cord astrocytes. We found that rodent spinal cord astrocytes
resulted in a delayed pattern of hiPSC-MN electrophysiological
maturation when compared with hiPSC-A. This difference para-
lleled qPCR profiling showing that the maturation of hiPSC-MN
was less robust when mouse astrocytes were used and phar-
macological testing showing only modest responses to drugs
acting on neurotransmitter receptors in human/mouse cocul-
tures This appears to be related to species differences rather
than regional heterogeneity since rodent astrocytes were
derived from the spinal cord. Our findings are in contrast to
those of Lischka et al. [49] who found that neonatal mouse
cortical but not isogenic human astrocyte feeder layers
enhanced the maturation of iPSC-N. It must be noted, how-
ever, that those investigators used a cortical patterning proto-
col to differentiate iPSC-N, mouse forebrains to derive rodent
astrocytes, and a patch-clamp platform to record neuronal
activity. Our observations may not be surprising as a growing
body of evidence suggests that human astrocytes are more
complex than their rodent counterparts, both morphologically
[50] and physiologically [50, 51]. We did not directly compare
molecular signatures of rodent astrocytes to hiPSC-A and,
therefore, cannot exclude that other factors besides species-
specific differences could explain our observations on neuronal
maturation.
Essential to the validation of this coculture strategy was
the demonstration that hiPSC-MN electrophysiological activity
was not merely spontaneous but would also respond to the
application of neurotransmitters and that their activity could
be inhibited by receptor antagonists. Consistent with the iden-
tity of these cells as iPSC-MN, in our coculture platform we
observed a robust and consistent response to AMPA receptor
agonists/antagonists (KA and CNQX, respectively). As shown by
others for hiPSC-cortical neurons [8, 9], this effect was
maturation-dependent, as it appeared only after 3–4 weeks
in vitro, whereas it was absent at earlier stages of maturation.
The response to the GABA antagonist bicuculline was less
robust, a finding consistent with a lower representation of
GABA receptors. In contrast, neuronal cultures without astro-
cytes did not show any response to neurotransmitter modula-
tors, which is consistent with our observations on the
immaturity of hiPSC-MN monocultures, and parallels previous
findings on hiPSC-cortical neurons [4, 8, 27].
Interestingly, the morphological and molecular characteri-
zation of our coculture platform showed that astrocyte matu-
ration, as defined by different glial-specific markers, was
enhanced by the presence of neurons. Even though the trends
of glial markers were similar for both ICC and qPCR studies,
some differences were noted, that can potentially be
explained by a differential regulation of transcription, transla-
tion, or protein trafficking. We also found that astrocyte matu-
ration was time dependent and marker dependent, as shown
by the profile of maturation of “immature” hiPSC-A
(i.e., hiPSC-A cultured for 60DIV prior to use) in coculture,
which was less marked than 90DIV hiPSC-A, with, however, the
exception of two markers, Cx43 and AQP4. These early
changes in AQP4 and Cx43 profiles suggest a neuronal influ-
ence on their expression not related to astrocyte maturation,
and parallels previous literature on rodent astrocytes showing
elevations in calcium intercellular signaling [52, 53] and
changes in astrocyte volume [54, 55] in response to neuronal
activity.
In a previous study [24], we analyzed the transcriptomic
profile of hiPSC-A after in vivo transplantation in the rat spinal
cord, and found marked increases of GFAP, EAAT2, Cx43, and
AQP4 [24]. Besides confirming these previous findings in vitro
and in a fully human hiPSC-based platform, our data suggest
that iPSC-A maturation in the spinal cord microenvironment
may be, at least partially, determined by the presence of
neurons.
Astrocyte–neuron crosstalk is relevant to our MEA plat-
form since hiPSC-MN electrophysiological maturation may be
influenced by the concurrent astrocyte maturation in
coculture. This is supported by the observation that immature
hiPSC-A in coculture with hiPSC-MN determined lower degrees
of neuronal activity on MEA. Furthermore, the pharmacologi-
cal effects of GAP19 and DHK on MEA activity paralleled
hiPSC-A maturation in coculture: GAP19 was active in both
early and late cocultures, which were characterized by a rela-
tively high expression of Cx43, but higher concentrations of
the drug were needed in older cultures in parallel to increased
levels of Cx43. DHK showed significant effects only after
3–4 weeks of coculture, when EAAT2 expression became rele-
vant. Although further experiments may be needed to clarify
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the mechanism of Cx43 and DHK influences on neuronal firing,
that were beyond the scope of this study, our data show the
feasibility of a MEA-based platform for testing drugs specifi-
cally targeting astrocytes.
CONCLUSION
In this study, we demonstrate that hiPSC-A influence the mor-
phological, molecular and electrophysiological maturation of
hiPSC-MN. Similarly, we show that hiPSC-A maturation is
enhanced by the presence of hiPSC-MN in coculture, thus all-
owing for a crosstalk that can be investigated with MEA. This
fully human, spinal cord-specific, coculture platform with MEA
analyses, provides a new tool for investigating astrocyte/MN
interactions and for screening pharmacological compounds
and has the potential to more accurately model human dis-
eases with spinal cord pathology, including spinal muscular
atrophy and amyotrophic lateral sclerosis.
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